Investigating the Interactions of AZD0530 With Alcohol in Social Drinkers

Summary

The purpose of this alcohol-interaction pilot study is to provide information on the effect of AZD0530 (Saracatinib) on the pharmacokinetics of alcohol and on alcohol responses, including stimulation, sedation, intoxication, body sway and physiological responses. The investigators propose to test the effects of a single dose of AZD0530 (125 mg) on alcohol related responses. This is a within subjects open label study in which the investigators plan to run 8 subjects to obtain 5 completers.

Timeline

Start

2015-11

Primary completion

2016-03-15

Completion

2016-03-23

Drugs

Indications